Tome Biosciences Overview
- Year Founded
-
2021
- Status
-
Out of Business
- Employees
-
130
- Latest Deal Type
-
Out of Business
Tome Biosciences General Information
Description
Operator of a biotechnology company intended to offer programmable gene insertion technology. The company helps to insert any genetic sequence of any size at any location in any genome to detect and destroy deoxyribonucleic acid from similar bacteriophages during subsequent infections, enabling patients to be cured through cell and genome engineering.
Contact Information
Website
www.tome.bioCorporate Office
- 100 Talcott Avenue
- Watertown, MA 02472
- United States
Corporate Office
- 100 Talcott Avenue
- Watertown, MA 02472
- United States
Tome Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 03-Nov-2025 | Completed | Out of Business | |||
| 2. Early Stage VC (Series B) | 12-Dec-2023 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 01-Jan-2022 | $95.5M | $95.5M | Completed | Generating Revenue |
Tome Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A-2 | ||||||||
| Series A | 24,306,564 | $0.000100 | 6% | $1.22 | $1.22 | 1x | $1.22 | 17.63% |
Tome Biosciences Comparisons
Industry
Financing
Details
Tome Biosciences Competitors (45)
One of Tome Biosciences’s 45 competitors is ERS Genomics, a Corporate Backed or Acquired company based in Dublin, Ireland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ERS Genomics | Corporate Backed or Acquired | Dublin, Ireland | ||||
| Regenxbio | Formerly VC-backed | Rockville, MD | ||||
| Selecta Biosciences | Formerly VC-backed | Watertown, MA | ||||
| Precision BioSciences | Formerly VC-backed | Durham, NC | ||||
| Genetix Biotherapeutics | Private Equity-Backed | Somerville, MA |
Tome Biosciences Patents
Tome Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025050069-A1 | Programmable gene insertion using engineered integration enzymes | Inactive | 01-Sep-2023 | ||
| WO-2024234006-A1 | Systems, compositions, and methods for targeting liver sinusodial endothelial cells (lsecs) | Inactive | 11-May-2023 | ||
| WO-2024138194-A1 | Platforms, compositions, and methods for in vivo programmable gene insertion | Inactive | 22-Dec-2022 | ||
| WO-2024020587-A2 | Pleiopluripotent stem cell programmable gene insertion | Inactive | 22-Jul-2022 | ||
| WO-2024020587-A3 | Pleiopluripotent stem cell programmable gene insertion | Inactive | 22-Jul-2022 | C12N15/1138 |
Tome Biosciences Signals
Tome Biosciences Acquisitions (1)
Tome Biosciences’s most recent deal was a Merger/Acquisition with Replace Therapeutics for . The deal was made on 02-Jan-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Replace Therapeutics | 02-Jan-2024 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology |
Tome Biosciences Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Replace Therapeutics | Emeryville, CA | 2022 |
Tome Biosciences FAQs
-
When was Tome Biosciences founded?
Tome Biosciences was founded in 2021.
-
Where is Tome Biosciences headquartered?
Tome Biosciences is headquartered in Watertown, MA.
-
What is the size of Tome Biosciences?
Tome Biosciences has 130 total employees.
-
What industry is Tome Biosciences in?
Tome Biosciences’s primary industry is Biotechnology.
-
Is Tome Biosciences a private or public company?
Tome Biosciences is a Private company.
-
What is Tome Biosciences’s current revenue?
The current revenue for Tome Biosciences is .
-
How much funding has Tome Biosciences raised over time?
Tome Biosciences has raised $213M.
-
Who are Tome Biosciences’s competitors?
ERS Genomics, Regenxbio, Selecta Biosciences, Precision BioSciences, and Genetix Biotherapeutics are some of the 45 competitors of Tome Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process